TFRC can transfer Fe2+ into cytoplasm, and increased cytosolic Fe2+ further facilitates the synthesis of ATP in cardiomyocytes and heme in erythroid precursors, which has been believed as a possible mechanism for the beneficial effect on major heart failure events of SGLT2i [20, 21]. The gene discussed is TFRC; the disease is heart failure.